Medibiofarma
Innovative and high quality research programs based on the modulation of clinically validated therapeutic targets for the treatment of cancer and non-cancer diseases.
Medibiofarma has raised €1.2M across 1 funding round from 5 investors, most recently a round in Mar 2022. Based in Navarre, Spain; active in Healthtech. Data as of 28 Oct 2026.
Navarre, Spainmedibiofarma.com ↗
Total raised
€1.2M
€1,200,000
Funding rounds
1
Investors
5
distinct backers
Active since
2022-03
latest 2022-03
Funding by year
EUR raised per yearMedibiofarma — funding by year — interactive chart.
Data table
| Medibiofarma — funding by year | |
|---|---|
| 2022 | €1.2M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Related news
- Medibiofarma consigue 1,2M€ en su tercera ronda de financiaciónelreferente.es · 2022-03
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData